CliffBio
small molecule

SERPASIL

RESERPINE

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameSERPASIL
Active ingredientRESERPINE
Strength2.5MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.